155 results match your criteria Lymphomas of the Head and Neck NK-Cell


Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell Lymphoma.

Transl Oncol 2020 Apr 13;13(5):100770. Epub 2020 Apr 13.

Department of Otolaryngology, Head and Neck Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan province, PR China. Electronic address:

Extranodal nasal natural killer (NK)/T cell lymphoma (ENKTCL) is a rare but highly aggressive subtype of non-Hodgkin lymphoma (NHL). Nevertheless, despite extensive research, the estimated 5-year overall survival of affected patients remains low. Therefore, new treatment strategies are needed urgently. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2020.100770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160598PMC

Brain Abscess as a Rare Complication of Primary Extranodal Nasal-type Natural Killer/T-cell Lymphoma.

Yonago Acta Med 2020 Feb 20;63(1):88-91. Epub 2020 Feb 20.

Department of Otolaryngology, Head and Neck Surgery, Yamagata University, Yamagata 990-1122.

We present the case of a 58-year-old Japanese woman with a natural killer T (NK/T)-cell lymphoma complicated by brain abscess. NK/T-cell lymphomas represent a rare type of lymphoma derived from either activated NK cells or, rarely, cytotoxic T cells. They are aggressive Epstein-Barr virus (EBV)-associated lymphomas that involve mainly the nasal cavity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.33160/yam.2020.02.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028533PMC
February 2020

[Misdiagnosis analysis: 120 patients with nasal extranodal NK/T cell lymphoma in head and neck].

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2020 Jan;34(1):73-78

Department of Otolaryngology,the First Affiliated Hospital of Nanjing Medical University.

The Clinicopathological characteristics and the reason of misdiagnosis about nasal extranodal NK/T cell lymphoma in head and neck(ENKTL) are analysised to raise awareness and reduce misdiagnosis. One hundred and twenty patients with ENKTL, diagnosed pathologically in head and neck from May 2010 to April 2018, were analyzed retrospectively. All cases were divided into misdiagnosed group and non-misdiagnosed group according to whether there were misdiagnosis and mistreatment before diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.13201/j.issn.1001-1781.2020.01.018DOI Listing
January 2020

[Advances in immunotherapy of extranodal NK/T cell lymphoma].

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019 Dec;54(12):949-953

Liaocheng People's Hospital, Otorhinolaryngology Head and Neck Surgery, Liaocheng 252000, China.

Extranodal NK/T-cell lymphoma (ENKTCL) is a relatively rare group of highly aggressive non-Hodgkin's lymphoma (NHL). The disease has rapid clinical progress, high degree of malignancy and poor prognosis. Traditional chemoradiotherapy regimens have not shown good efficacy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1673-0860.2019.12.015DOI Listing
December 2019

Extranodal natural killer/T cell lymphoma, nasal type: a diagnostic challenge.

BMJ Case Rep 2019 Nov 28;12(11). Epub 2019 Nov 28.

Otorhinolaryngology, Hospital da Senhora da Oliveira Guimarães, Guimaraes, Braga, Portugal.

Extranodal natural killer/T cell lymphoma, nasal type (ENKL) is a rare and aggressive tumour that can, clinically and histologically, mimic infectious and inflammatory conditions, presenting a diagnostic challenge. The authors report the case of a 69-year-old Portuguese woman previously misdiagnosed with chronic recurrent sinusitis. Despite maximal medical and surgical treatments, the disease was refractory and progressed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2019-232404DOI Listing
November 2019

Nasopharyngeal Lymphoma: A 22-Year Review of 35 Cases.

J Clin Med 2019 Oct 3;8(10). Epub 2019 Oct 3.

Department of Otorhinolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan.

Nasopharyngeal (NP) lymphoma is a rare primary malignancy of the head and neck and represents a minority of malignancies originating from the nasopharynx. For this reason, there are limited data regarding epidemiologic and treatment outcomes. This is a retrospective review of patients diagnosed with NP lymphoma from 1995 to 2017 at a tertiary medical center. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8101604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833098PMC
October 2019
2 Reads

[Clinical observation of LOP chemotherapy combined with radiotherapy in the treatment of early nasal NK/T cell lymphoma].

Authors:
W B Ai Q C Jing

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019 Oct;33(10):990-992

Department of Otorhinolaryngology Head and Neck Surgery,the Second Affiliated Hospital of Nanhua University,Hengyang,421001,China.

To investigate the efficacy and safety of LOP(asparaginase + vincristine + dexamethasone) chemotherapy combined with radiotherapy in patients with nasal NK/T cell lymphoma. Sixty patients with nasal NK/T cell lymphoma admitted to our hospital from February 2012 to February 2016 were selected as the study subject. They were randomly divided into group A and group B, 30 cases in each group. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.13201/j.issn.1001-1781.2019.10.022DOI Listing
October 2019
1 Read

A Diagnostic Dilemma of Sinonasal T Cell Lymphoma: Report of A Unique Case and Literature Review.

Gulf J Oncolog 2019 Sep;1(31):83-89

Department of Otorhinolaryngology - Head and Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia.

Background: Natural Killer/T-cell non-Hodgkin lymphomas are rare and aggressive disease of non-Hodgkin lymphoma characterized by angioinvasion, angiodestruction and necrosis. It has a strong association with Epstein-Barr virus (EBV) as the lymphoma cells are almost invariably infected with the clonal episomal form of EBV. Because of their rarity, it is a challenge to diagnose and treat them even to the experienced pathologists. Read More

View Article

Download full-text PDF

Source
September 2019
1 Read

Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.

Eur Radiol 2020 Jan 1;30(1):110-118. Epub 2019 Aug 1.

Department of MRI, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe Dong Road, Zhengzhou, 450000, Henan, People's Republic of China.

Objectives: To explore the utility of dynamic contrast-enhanced MRI (DCE-MRI) and readout-segmented diffusion-weighted imaging (RESOLVE-DWI) in the differentiation of nasopharyngeal carcinoma (NPC) and nasopharyngeal lymphoma (NPL).

Methods: Sixty-two patients with NPC and 39 patients with NPL who underwent DCE-MRI and RESOLVE-DWI examinations were evaluated. The time signal-intensity curve (TIC) types, time to peak (TTP), enhancement peak (EP), maximum contrast enhancement ratio (MCER), washout ratio (WR), apparent diffusion coefficient (ADC), and relative ADC (rADC) values were calculated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-019-06343-0DOI Listing
January 2020
3 Reads

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress.

Front Pediatr 2019 16;7:141. Epub 2019 Apr 16.

Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.

Extranodal natural killer (NK)/T-cell lymphoma, nasal type (NNKTL) has very unique epidemiological, etiologic, histologic, and clinical characteristics. It is commonly observed in Eastern Asia, but quite rare in the United States and Europe. The progressive necrotic lesions mainly in the nasal cavity, poor prognosis caused by rapid local progression with distant metastases, and angiocentric and polymorphous lymphoreticular infiltrates are the main clinical and histologic features. Read More

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fped.2019.00141/
Publisher Site
http://dx.doi.org/10.3389/fped.2019.00141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476925PMC
April 2019
8 Reads

Prognostic significance of locally invaded sites and tissue types in patients with nasal extranodal natural-killer/T-cell lymphoma: a single-center retrospective analysis.

Chin Med J (Engl) 2019 Jun;132(11):1305-1313

Department of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.

Background: Extranodal natural killer/T-cell lymphoma (ENKTL), nasal type, is an aggressive entity within the World Health Organization classification of lymphoid tumors. The International Prognostic Index is reported to be prognostically meaningful for ENKTL, but lacks discriminatory power for stage I/II ENKTL with extensive local invasion. This study aimed to evaluate the prognostic effects of local invasion by site and tissue type in patients with ENKTL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CM9.0000000000000263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629357PMC
June 2019
21 Reads

Extranodal NK/T-Cell Lymphoma, Nasal Type in Guatemala: An 86-Case Series Emphasizing Clinical Presentation and Microscopic Characteristics.

Head Neck Pathol 2019 Dec 21;13(4):624-634. Epub 2019 Mar 21.

Centro Clínico de Cabeza y Cuello, Guatemala City, Guatemala.

Extranodal NK/T-cell lymphoma, nasal type (ENKTCL-NT) is a lymphoid malignancy that mainly affects the nasopharynx and is associated with the Epstein-Barr virus (EBV). Increased incidence is seen in some Latin American and Asian countries. In this study, we describe a case series of 86 Guatemalan patients with ENKTCL-NT from a single diagnostic head and neck center. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12105-019-01027-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854135PMC
December 2019
10 Reads

Extranodal NK/T cell lymphoma, nasal type, with retrobulbar extraconal phlegmon and naso-oral fistula.

BMJ Case Rep 2019 Mar 9;12(3). Epub 2019 Mar 9.

Department of Otolaryngology, Head and Neck Surgery, Barwon Health, Geelong, Victoria, Australia.

Extranodal natural killer (NK-)/T cell lymphoma, nasal type (ENKL), is a rare disease that often mimics rheumatological and infectious conditions and can therefore be difficult to diagnose. The authors present a case of a 55-year-old Vietnamese woman who was misdiagnosed with severe atrophic rhinitis and chronic sinus osteitis. Over a period of 8 months from initial referral, she underwent multiple biopsies and was treated with various antimicrobial regimens until the histopathological diagnosis of ENKL was finally made. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2018-227160DOI Listing
March 2019
11 Reads

[Effectiveness of P-Gemox chemotherapy combined with radiotherapy in newly diagnosed,stage ⅠE to ⅡE, extranodal nasal type natural killer/T-cell lymphoma].

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019 Feb;33(2):132-137

The First Clinical Medical College of Lanzhou University.

To investigate the efficacy and safety of pegaspargase, gemcitabine, and oxaliplatin(P-Gemox) chemotherapy combined with radiotherapy in the treatment of newly diagnosed, stage IE to IIE of Extranodal nasal type natural killer/T-cell lymphoma(ENKTL) patients. P-Gemox chemotherapy combined with radiotherapy was used to analyze its clinical value and the factors affecting the prognosis in the treatment of 43 newly diagnosed ENKTL patients. In addition, toxicity related to chemotherapy was assessed. Read More

View Article

Download full-text PDF

Source
http://www.cnki.net/kcms/doi/10.13201/j.issn.1001-1781.2019.
Publisher Site
http://dx.doi.org/10.13201/j.issn.1001-1781.2019.02.010DOI Listing
February 2019
8 Reads

Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.

Laryngoscope 2019 12 23;129(12):2675-2680. Epub 2019 Feb 23.

Department of Otorhinolaryngology-Head and Neck Surgery, Rush Sinus Program, Rush University Medical Center, Rush University Medical Center, Chicago, Illinois, U.S.A.

Objectives: Extranodal natural killer/T-cell lymphoma (ENKTL) is a highly aggressive tumor of the sinonasal tract associated with poor overall survival (OS). This study expands upon epidemiologic, prognostic, and treatment factors for OS and disease-specific survival (DSS), incorporating newly accessible chemotherapy data.

Methods: Retrospective population-based cohort study performed on cases of sinonasal ENKTL identified through the Surveillance, Epidemiology, and End Results database. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.27886DOI Listing
December 2019
7 Reads

Extranodal NK/T-cell lymphoma in adolescents: imaging findings of a consecutive 7-year case series.

J Int Med Res 2019 Mar 6;47(3):1210-1220. Epub 2019 Feb 6.

1 Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.

Objectives: Extranodal NK/T-cell lymphoma is reportedly a rare but emerging type of lymphoma in adolescents. The present study was performed to specify its imaging characteristics.

Methods: Our hospital's picture archiving and communication systems were searched from January 2009 to December 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300060518822406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421368PMC
March 2019
10 Reads

Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma.

Lab Invest 2019 May 21;99(5):612-624. Epub 2019 Jan 21.

Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.

Nasal natural killer/T-cell lymphoma (NNKTL) is closely associated with Epstein-Barr virus (EBV) and is characterized by poor prognosis, resulting from rapid progression of lesions in the affected organs. Recent data have shown that NNKTL is associated with the aberrant expression of cyclin-dependent kinase 1 (CDK1) and its downstream target survivin, but little is known about the functional roles of CDK1 and survivin in NNKTL. In the current study, we show that knockdown of the EBV-encoded oncoprotein latent membrane protein 1 (LMP1) induces downregulation of CDK1 and survivin in NNKTL cells. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41374-018-0182-9DOI Listing
May 2019
8 Reads
3.676 Impact Factor

A Survival Analysis of Pediatric Tonsillar Malignancies and Review of a Rare Case.

Int J Pediatr Otorhinolaryngol 2019 Mar 28;118:160-164. Epub 2018 Dec 28.

University of Central Florida College of Medicine, Orlando, FL, USA; Division of Otolaryngology, Nemours Children's Hospital, Orlando, FL, USA. Electronic address:

Objective: To examine the survival of pediatric tonsillar cancer patients and review a rare case of pediatric tonsillar cancer.

Methods: Pediatric patients in the Surveillance, Epidemiology, and End Results (SEER) database were included from 1973 to 2014 based on a diagnosis of tonsillar malignancy using the ICD O-3 tonsil primary site codes of: C09.0, C09. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01655876183064
Publisher Site
http://dx.doi.org/10.1016/j.ijporl.2018.12.033DOI Listing
March 2019
22 Reads

Acute Epstein-Barr virus-positive cytotoxic T cell lymphoid hyperplasia in the upper aerodigestive tract, mimicking extranodal natural killer/T cell lymphoma, nasal type.

Virchows Arch 2019 Feb 28;474(2):219-226. Epub 2018 Nov 28.

Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.

To describe the clinicopathological features of nine patients with acute Epstein-Barr virus (EBV)-positive cytotoxic T cell lymphoid hyperplasia (EBV+TLH) in the upper aerodigestive tract, in which initial findings led to a preliminary misdiagnosis of extranodal NK/T cell lymphoma, nasal type (ENKTL). A series of nine cases of EBV+TLH in one Chinese institution over a 9-year interval was retrospectively analyzed. Median age was 16 years (range 5-29 years) with a M:F ratio of 5:4. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-018-2498-7DOI Listing
February 2019
9 Reads

Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer.

Oncoimmunology 2018 1;7(9):e1471440. Epub 2018 Aug 1.

National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA.

Head and neck squamous cell carcinomas (HNSCCs) frequently harbor genomic mutations in cell death pathways. Nearly 30% of HNSCCs overexpress Fas-Associated Death Domain (FADD), with or without BIRC2/3 genes encoding cellular Inhibitor of Apoptosis Proteins 1/2 (cIAP1/2), critical components of the Tumor Necrosis Factor (TNF) Receptor signaling pathways. ASTX660 is a novel non-peptidomimetic antagonist of cIAP1/2 and XIAP under evaluation in a clinical trial for advanced solid tumors and lymphomas. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2018.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2018.1471440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209421PMC
August 2018
45 Reads

Extranodal lymphomas in the public health system in Chile: Analysis of 1251 patients from the National Adult Cancer Program.

Hematol Oncol 2019 Feb 14;37(1):47-53. Epub 2018 Sep 14.

Medicine Service, Hematology Section, Hospital del Salvador, University of Chile, Santiago, Chile.

The aim of the study was to describe the clinical and epidemiological characteristics, anatomic and histologic distribution, and treatment results of extranodal lymphomas (ENLs), diagnosed and treated in the public health system in Chile. We included patients with ENL diagnosed from 1998 to 2014, in 17 cancer centers, registered prospectively in the database of the National Adult Cancer Program (PANDA) of the Ministry of Health. Treatment was based on the local protocols for each lymphoma subtype. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.2547
Publisher Site
http://dx.doi.org/10.1002/hon.2547DOI Listing
February 2019
16 Reads

Lymphoma associated hemophagocytic syndrome: A single-center retrospective study.

Oncol Lett 2018 Jul 22;16(1):1275-1284. Epub 2018 May 22.

Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.

To improve the understanding of lymphoma associated hemophagocytic syndrome (LAHS) and find an effective treatment for this fatal disease, 57 patients with LAHS were retrospectively reviewed. The most common histopathological type was extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKL) (45.61%). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2018.8783DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063042PMC
July 2018
31 Reads
0.990 Impact Factor

[Laryngeal NK/T cell lymphoma mainly manifested as sore throat, hoarseness, fever: a case report].

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018 Jun;53(6):448-449

Department of Otorhinolaryngology Head and Neck Surgery, the Third Hospital of Peking University, Beijing100191, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1673-0860.2018.06.012DOI Listing
June 2018
5 Reads

Clinical manifestation of malignant lymphomas of the head and neck region.

Otolaryngol Pol 2017 Dec;71(6):14-21

Department of Otorhinolaryngology, Medical University of Lodz, Poland.

Introduction: Malignant lymphoma (ML) is a neoplasm caused by clonal expansion of undifferentiated B, T and NK-lymphoid cells. WHO classification divides lymphomas into two main types, i.e. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/01.3001.0010.7192DOI Listing
December 2017
9 Reads

Systemic Non-Hodgkin T Cell Lymphomas Presenting in the Head and Neck Region: An Institutional Experience of a Rare Entity.

Head Neck Pathol 2018 Dec 4;12(4):481-487. Epub 2018 Jan 4.

Department of Pathology, University of Alabama at Birmingham, 1802 6th Ave S, NP 3545, Birmingham, AL, 35233-7331, USA.

T cell lymphoma (TCL) is a group of rare and aggressive diseases. TCL primary to head and neck organs often present as extranodal NK/T cell lymphoma, nasal type. Systemic TCL with initial head and neck presentation is extremely rare. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12105-017-0881-3
Publisher Site
http://dx.doi.org/10.1007/s12105-017-0881-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232224PMC
December 2018
9 Reads

Copanlisib: First Global Approval.

Authors:
Anthony Markham

Drugs 2017 Dec;77(18):2057-2062

Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand.

Bayer are developing copanlisib (Aliqopa™)-a pan-class I phosphoinositide 3-kinase (PI3K) inhibitor-as a treatment for various haematological and solid malignancies. The US FDA has granted copanlisib accelerated approval for the treatment of adults with relapsed follicular lymphoma who have received at least two prior systemic therapies based on the results of a phase II trial. Phase III trials are underway evaluating copanlisib as treatment for relapsed/refractory diffuse large B-cell lymphoma and in combination with rituximab or rituximab-based chemotherapy or standard immunochemotherapy in patients with relapsed indolent B-cell non-Hodgkin's lymphoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-017-0838-6DOI Listing
December 2017
9 Reads

Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.

Int J Hematol 2018 Jan 30;107(1):98-104. Epub 2017 Aug 30.

Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Dong Jiao Min Xiang Street, No.1, Dong Cheng District, Beijing, 10073, China.

Extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) is a rare disease with a poor prognosis. The long-term effect of autologous hematopoietic stem cell transplantation (auto-HSCT) on ENKTL has been reported occasionally but needs further investigation. In this retrospective study from a single center, 20 ENKTL patients who received induction chemotherapy followed by auto-HSCT ± involved-field radiotherapy (IFRT) ± additional chemotherapy were enrolled as a study group. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-017-2324-zDOI Listing
January 2018
33 Reads

Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case report.

BMC Cancer 2017 Jul 28;17(1):507. Epub 2017 Jul 28.

Department of oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.

Background: Extranodal natural killer/T-cell lymphoma (NKTCL), nasal type, is an aggressive malignancy with poor prognosis. Currently, there is no recommended standard therapy for relapsed NKTCL.

Case Presentation: A 37-year-old woman with lymphadenopathy was diagnosed with NKTCL by biopsy of an enlarged lymph node on the right side of her neck. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3501-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534108PMC
July 2017
46 Reads

Deceptive nasal NK/T-cell lymphoma.

Trop Doct 2017 Jul 20;47(3):268-271. Epub 2016 Dec 20.

3 Professor, Department of Otolaryngology-Head and Neck Surgery (ENT), Indira Gandhi Medical College, Shimla, HP, India.

Nasal NK/T cell lymphoma is rare and it easily masquerades as chronic rhinosinusitis. It has a very poor prognosis and hence early diagnosis, although difficult, is necessary for better outcome. We present a case of a 30-year-old man who presented with nasal obstruction, facial oedema and crusts. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0049475516684088DOI Listing
July 2017
18 Reads

Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.

Head Neck Pathol 2018 Mar 14;12(1):89-94. Epub 2017 Jun 14.

Department of Pathology, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Pathology Building, Room 401, Baltimore, MD, 21287, USA.

NKX2.2 is a new immunohistochemical marker that has been reported to be sensitive and specific for Ewing sarcoma (ES). It has not, however, been investigated specifically in the sinonasal small round blue cell tumor (SRBCT) differential diagnosis which includes many tumors specific to that site. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12105-017-0830-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873485PMC
March 2018
26 Reads

Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.

Cancer Immunol Immunother 2017 Jul 27;66(7):877-890. Epub 2017 Mar 27.

Department of Pathology, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Nasal natural killer/T-cell lymphoma (NNKTL) is an aggressive neoplasm with poor therapeutic responses and prognosis. The programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) pathway plays an important role in immune evasion of tumor cells through T-cell exhaustion. The aim of the present study was to examine the expression of PD-L1 and PD-1 molecules in NNKTL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-1987-xDOI Listing
July 2017
31 Reads

Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.

Otolaryngol Head Neck Surg 2017 05 21;156(5):870-876. Epub 2017 Mar 21.

1 Department of Head and Neck Surgery, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, California, USA.

Objectives To describe the incidence and determinants of survival of patients with nasopharyngeal lymphoma (NPL) between 1973 and 2012 using the Surveillance, Epidemiology, and End Results (SEER) database. Study Design Retrospective cohort study using a national database. Methods The SEER registry was used to calculate survival trends for patients with NPL between 1973 and 2012. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0194599817695808DOI Listing
May 2017
19 Reads

[Extranodal NK/T-cell lymphoma, nasal type: a clinical analysis].

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2017 Mar;31(5):327-333

Department of Otorhinolaryngology-Head and Neck Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.

To explore the clinical diagnosis and treatment characteristics and clinical factors of extranodal NK/T-cell lymphoma, nasal type and provide the basis for clinical individual therapy and experience.The 25 cases personal data of ENKTL received from December in 2009 to July in 2016 by our department including clinical manifestation, the serum EBV-DNA detection, imaging examination, Ann-Arbor staging, histological grade, treatment, and prognosis, etc. were retrospectively analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.13201/j.issn.1001-1781.2017.05.001DOI Listing
March 2017
2 Reads

Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.

Am J Case Rep 2016 Dec 9;17:934-938. Epub 2016 Dec 9.

Department of Otolaryngology, Hamad Medical Corporation, Doha, Qatar.

BACKGROUND Extranodal lymphoma of the paranasal sinuses is a rare clinical entity seen in only 5-8% of extranodal lymphomas of the head and neck. Nasal natural killer/T cell lymphoma (Nasal NKTCL), which is a subtype of peripheral T cell lymphoma, constitutes about 1.4% of all lymphomas. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153321PMC
http://dx.doi.org/10.12659/ajcr.899922DOI Listing
December 2016
14 Reads

Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy.

Ann Oncol 2017 02;28(2):415-420

Department of Medicine, Division of Oncology, Stanford University , Stanford, CA, USA.

Background: In the era of personalized cancer medicine, identifying techniques for effectively matching patients to efficacious treatments is a critical step in the treatment process. The advent of anti-cancer immunotherapies necessitates novel approaches to biomarker identification beyond traditional genomic profiling. One promising approach is incorporation of nomograms into treatment decisions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/annonc/mdw570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246233PMC
February 2017
6 Reads

Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.

Hematol Oncol 2017 Dec 6;35(4):655-663. Epub 2016 Oct 6.

Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.

Nasal natural killer/T-cell lymphoma (NNKTL) is an Epstein-Barr virus (EBV)-associated malignancy and is characterized by local invasion and widespread dissemination, with a consequent poor prognosis. Micro-RNAs (miRNAs) play roles in the pathogenesis of several malignancies by regulating gene expression and have been recently identified as stable entities in serum. Here, we investigated the value of circulating EBV-miRNAs as biomarkers for NNKTL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2360DOI Listing
December 2017
43 Reads

A 14-year-old boy with extranodal natural killer cell lymphoma of the nose, nasopharynx, larynx, and trachea in remission 6years after primary diagnosis. A longitudinal case report.

Am J Otolaryngol 2016 Nov - Dec;37(6):563-566. Epub 2016 Aug 12.

Department of Pediatric Hematology and Oncology, LSUHSC-Shreveport, Shreveport, LA, United States.

Nasal type extranodal natural killer/T-cell lymphoma (ENKTL) is a rare lymphoma in the USA and Europe but endemic in East Asia and in areas of South and Central America. Clinically natural killer cell lymphomas are divided into three categories; nasal, non-nasal and aggressive lymphoma/leukemia subtypes. ENKTL, nasal type occurs in the nose and can extend to the upper aero-digestive tract as reported in this longitudinal case study. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01960709163022
Publisher Site
http://dx.doi.org/10.1016/j.amjoto.2016.08.004DOI Listing
September 2017
13 Reads

[Role of radiotherapy in the treatment of NK/T-cell nasal type and primary cerebral lymphomas].

Cancer Radiother 2016 Oct 7;20(6-7):535-42. Epub 2016 Sep 7.

Département d'oncologie radiothérapie, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France; Université Paris Saclay, 15, rue Georges-Clemenceau, 91400 Orsay, France. Electronic address:

The head and neck are common sites for extranodal non-Hodgkin lymphomas. Radiotherapy plays an important role in the treatment of low-grade lymphomas, with curative or palliative intent. In the case of high-grade lymphomas, its combination with chemotherapy is debated. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S12783218163035
Publisher Site
http://dx.doi.org/10.1016/j.canrad.2016.07.078DOI Listing
October 2016
7 Reads

Delayed diagnosis of sinonasal lymphoma due to bilateral manifestation.

Eur Arch Otorhinolaryngol 2017 Feb 31;274(2):823-827. Epub 2016 Aug 31.

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Zurich and University of Zurich, Frauenklinikstr. 24, 8091, Zurich, Switzerland.

The objective of this study is to analyze the presenting symptoms, the time to correct diagnosis and outcome of a European patient cohort with sinonasal lymphoma focusing on unilateral vs. bilateral sinonasal involvement. In a retrospective setting in a European tertiary referral center, eleven patients (9 males, 2 females) with sinonasal lymphoma diagnosed between 2002 and 2015 were identified and divided into a unilateral and bilateral group according to their CT finding. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00405-016-4275-z
Publisher Site
http://dx.doi.org/10.1007/s00405-016-4275-zDOI Listing
February 2017
10 Reads

A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.

Oncotarget 2016 May;7(19):27764-77

Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA.

Breast cancer brain metastases (BCBMs) are common in patients with metastatic breast cancer and indicate a poor prognosis. These tumors are especially resistant to currently available treatments due to multiple factors. However, the combination of chimeric antigen receptor (CAR)-modified immune cells and oncolytic herpes simplex virus (oHSV) has not yet been explored in this context. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053686PMC
http://dx.doi.org/10.18632/oncotarget.8526DOI Listing
May 2016
57 Reads

Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience.

Jpn J Radiol 2016 Apr 6;34(4):292-9. Epub 2016 Feb 6.

Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

Purposes: The prognosis of localized extranodal natural killer/T-cell lymphoma, nasal type (ENKTL), has improved with the development of chemoradiotherapy. However, conventional extended-field radiotherapy may cause optic disorders. Our group has employed smaller radiation fields in an attempt to avoid toxicity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11604-016-0524-8DOI Listing
April 2016
35 Reads

[Extranodal natural killer/T-cell lymphoma, nasal type developing central nervous system and epididymis involvement immediately after concurrent chemoradiotherapy].

Rinsho Ketsueki 2015 Dec;56(12):2472-6

Department of Hematology, Kokura Memorial Hospital.

A 66-year-old man showed central nervous system (CNS) and epididymis involvement after concurrent chemoradiotherapy for extranodal natural killer/T-cell lymphoma, nasal type (ENKL). The patient experienced continuous nasal obstruction. CT revealed a mass in the nasal cavity and paranasal sinuses. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.56.2472DOI Listing
December 2015
16 Reads

Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy.

Hematol Oncol 2017 Jun 13;35(2):158-162. Epub 2015 Nov 13.

Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Nasal natural killer (NK)/T-cell lymphoma (NNKTL) displays unusual clinicopathological features, and the prognosis is very poor, even in the early stages of the disease. For early stage NNKTL, we have developed a novel chemoradiotherapy regimen incorporating arterial infusion chemotherapy, administered via the superficial temporal artery, in combination with radiotherapy. The novel arterial infusion regimen consists of ifosfamide, carboplatin, methotrexate, peplomycin, and etoposide (MPVIC-P). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2273DOI Listing
June 2017
38 Reads

A comparison of volumetric modulated arc therapy and sliding-window intensity-modulated radiotherapy in the treatment of Stage I-II nasal natural killer/T-cell lymphoma.

Med Dosim 2016 1;41(1):42-6. Epub 2015 Oct 1.

Department of Radiation Oncology, Chongqing Cancer Institute, Chongqing, PR China. Electronic address:

This article is aimed to compare the dosimetric differences between volumetric modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) for Stage I-II nasal natural killer/T-cell lymphoma (NNKTL). Ten patients with Stage I-II NNKTL treated with IMRT were replanned with VMAT (2 arcs). The prescribed dose of the planning target volume (PTV) was 50Gy in 25 fractions. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09583947150010
Publisher Site
http://dx.doi.org/10.1016/j.meddos.2015.07.003DOI Listing
December 2016
31 Reads

A TNM Staging System for Nasal NK/T-Cell Lymphoma.

PLoS One 2015 22;10(6):e0130984. Epub 2015 Jun 22.

Stage Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China; Medical Imaging Department, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.

Ann Arbor stage has limited utility in the prognostication and treatment decision making in patients with NK/T-cell lymphoma (NKTCL), as NKTCL is almost exclusively extranodal and the majority is localized at presentation for which radiotherapy is the most important treatment and local invasiveness is the most important prognostic factor. In this study, we attempted to establish a TNM (Tumor-Node-Metastasis) staging system for nasal NKTCL (N-NKTCL). The staging rules of other head and neck cancers were used as reference along with the data of our 271 eligible patients. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0130984PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476596PMC
March 2016
64 Reads

Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type.

Int Forum Allergy Rhinol 2015 Oct 3;5(10):960-6. Epub 2015 Jun 3.

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Background: Endoscopic findings of extranodal natural killer/T-cell lymphoma (ENKTL), nasal type, are heterogeneous, but not fully understood. The objective of this study was to evaluate the role of nasal endoscopic examination and its implications for treatment of stage I/II ENKTL.

Methods: This retrospective study included 60 consecutive patients diagnosed with stage I/II ENKTL, nasal type, from 2000 to 2011. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/alr.21564DOI Listing
October 2015
24 Reads

Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.

Mol Ther 2015 Aug 28;23(8):1401-1409. Epub 2015 May 28.

Department of Microbiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul, Korea. Electronic address:

Extranodal NK/T-cell lymphoma (ENKTCL) is associated with latent Epstein-Barr virus (EBV) infection and frequent relapse even after complete response (CR) to intensive chemotherapy and radiotherapy. The expression of EBV proteins in the tumor provides targets for adoptive immunotherapy with antigen-specific cytotoxic T cells (CTL). To evaluate the efficacy and safety of EBV latent membrane protein (LMP)-1 and LMP-2a-specific CTLs (LMP1/2a CTLs) stimulated with LMP1/2a RNA-transferred dendritic cells, we treated 10 ENKTCL patients who showed complete response to induction therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2015.91DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817864PMC
August 2015
71 Reads

c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma.

Oncoimmunology 2015 Feb 6;4(2):e976077. Epub 2015 Mar 6.

Department of Pathology; Asahikawa Medical University ; Asahikawa, Japan.

The expression of c-Met and its ligand HGF plays a critical role in cell proliferation and is involved in numerous malignancies. Because c-Met expression and its role in NK/T-cell lymphoma remain unclear, we studied the expression and function of c-Met in NK/T-cell lymphoma cells. In addition, we investigated the possibility that c-Met could function as a tumor-associated antigen for helper T lymphocytes (HTLs). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/2162402X.2014.976077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404796PMC
February 2015
32 Reads

CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.

Cancer Immunol Immunother 2015 Jun 10;64(6):697-705. Epub 2015 Mar 10.

Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Nasal natural killer/T-cell lymphoma (NNKTL) is associated with Epstein-Barr virus and has a poor prognosis because of local invasion and/or multiple dissemination. Various chemokines play a role in tumor proliferation and invasion, and chemokine receptors including the C-C chemokine receptor 4 (CCR4) are recognized as potential targets for treating hematologic malignancies. The aim of the present study was to determine whether specific chemokines are produced by NNKTL. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-015-1675-7
Publisher Site
http://dx.doi.org/10.1007/s00262-015-1675-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648286PMC
June 2015
49 Reads

Nasal type natural killer T-cell lymphoma involving nasooropharynx and larynx.

Kulak Burun Bogaz Ihtis Derg 2014 Nov-Dec;24(6):364-7

Department of Otolaryngology, Medical Faculty of Abant İzzet Baysal University, 14280 Gölköy, Bolu, Turkey.

Lymphoma is one of the malignant non-squamous tumors involving the head and neck. Lymphomas in this region are mostly B-cell type in origin and usually seen in Waldeyer's ring. In this article, we report a 45-year-old female case of primary natural killer T cell lymphoma-nasal type involving the nasooropharynx and larynx. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5606/kbbihtisas.2014.86619DOI Listing
October 2015
26 Reads